Science

Feb 24, 2025, 10:10

Myeloma Paper of the Day, February 24th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Amyloidosis Forum Imaging Proceedings notes endpoints can provide valuable info for proof of concept, dose selection and may support extrapolation of results to related populations or subgroups not sufficiently represented.”

“Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum”

Authors: Sharmila Dorbala, Rosalyn Adigun, Kevin Alexander, Cynthia Welsh, Isabelle Lousada et al.

More posts featuring Robert Orlowski.

AL Amyloidosis amyloidosis Amyloidosis Forum ATTR Amyloidosis cancer Cynthia Welsh Isabelle Lousada Kevin Alexander Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski Rosalyn Adigun Sharmila Dorbala

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC